Condition: Mitral Valve Insufficiency · Sponsor: Asan Medical Center
The purpose of this study is to evaluate the early and mid-term safety and performance of the MITRIS RESILIA mitral valve in Asian patients in a real-world setting
This description comes directly from the study's public registry record.
HOJIN KIM, PI · 82-2-3010-0506 · rhonin.hojin@gmail.com
YUKYUNG CHOI, CRA · 82-2-2045-3815 · cyk1108@amc.seoul.kr
Always discuss trial participation with your own doctor first.
| Asan Medical Center | Seoul, SONGPA-GU, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06757049